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Abstract  
The diagnosis and treatment of endometrial polyps will be familiar to most gynaecologists. However, 
the aetiology and natural history of these focal intrauterine lesions is far from clear. This lack of 
clarity is also true as regards their clinical significance; whilst endometrial polyps are highly prevalent 
in all types of abnormal uterine bleeding (AUB) they are also commonly found in women without 
AUB. These controversies will be discussed along with current thoughts on the diagnosis and 
treatment of endometrial polyps. Criteria for diagnosis of uterine polyps vary according to the test 
used, but optimal testing is not yet solidified. Recent data from randomised trials evaluating new 
and established surgical technologies as well as comparing treatment protocols and settings will be 
examined. 
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[A] Introduction 
 
[A] Relationship of endometrial polyps to abnormal uterine bleeding 
 
[B] Definition  
Uterine polyps are focal endometrial outgrowths that can occur anywhere within the uterine cavity. 
They contain a variable amount of glands, stroma and blood vessels, the relative amounts of which 
influence their visual appearance at hysteroscopy. Polyps may be soft and cystic or firm and fibrous; 
they may be pedunculated or sessile, single or multiple, and vary in size from small – with minimal 
uterine cavity distortion – to large, filling the whole cavity (Figure 1) [1].  
Most endometrial polyps are diagnosed on imaging via transvaginal pelvic ultrasound (TVS) or 
hysteroscopy and confirmation is provided by histological examination of the removed specimen. 
Thus, in clinical practice the features that define an endometrial polyp will relate to the diagnostic 
modality, although agreed, standardised definitions are lacking (Table 1).  
 
[B] Aetiology  
The underlying mechanism of uterine polyp formation remains unclear but is believed to be 
multifactorial [2]. Uterine polyps are thought to start as focal areas of stromal and glandular 
overgrowth within the endometrium [3, 83]. The effect of hormones on polyp formation is unclear 
and may differ according to menopausal status. In premenopausal women, a decrease in oestrogen 
and progesterone receptors within polyp stromal cells may make polyps less sensitive to cyclic 
hormonal changes [4, 84].  Increased cell longevity may also play a role in the genesis of polyps as a 
result of inhibition of apoptosis [5] and altered gene expression [6, 7].  
 
[B] Epidemiology 
 
[C] Prevalence 
The prevalence of uterine polyps in a general adult female population without abnormal uterine 
bleeding (AUB) is generally estimated to be around 10-15% [8]. Uterine polyps were detected 
incidentally during TVS in 12% of premenopausal women and in 6–11% of infertile women without 
AUB [9] [10]. In asymptomatic postmenopausal women undergoing TVS a polyp prevalence of 13% 
was found [11] and 16% [12, 13] during hysteroscopy. Risk factors for uterine polyp development are 
thought to include obesity, late menopause and the use of the partial oestrogen agonist tamoxifen 
[11, 14, 15].  The role of hormone replacement therapy (HRT) on polyp formation is unclear, with 
some studies supporting an association [11, 13] and others not [16, 17]. 
Whilst uterine polyps may be an incidental finding, they appear to be more prevalent in women 
undergoing investigation with high-resolution pelvic ultrasound or hysteroscopy for AUB. The 
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prevalence of polyps found associated with AUB varies according to the criteria used to define a 
polyp, the diagnostic test used, and the type of population studied. In general, the prevalence of 
endometrial polyps is considered to be between 20% and 30% [16,18,19]. Uterine polyps affect pre- 
and postmenopausal women with AUB 46 and indeed the prevalence may be increased after the 
menopause [11].  
The high frequency in which uterine polyps are discovered in women of reproductive age and the 
likely causative association between uterine polyps and AUB has been recognised in the 
International Federation of Gynecology and Obstetrics (FIGO) classification system for causes of AUB 
during the reproductive years. This nomenclature is based upon the acronym ‘PALM-COEIN’ with the 
‘P’ denoting a ‘polyp’, i.e. describing AUB associated with the presence of uterine polyps (AUB-P) 
[20].  
 
[C] Natural history 
Most uterine polyps will persist if left untreated although small polyps may spontaneously regress 
[21]. In a small cases of asymptomatic premenopausal women 27% of polyps naturally regressed 
after one year of follow-up be smaller, in keeping with an earlier case series [22].  
The majority of uterine polyps are benign. Estimates of the prevalence of hyperplasia and cancer 
vary across study populations. A systematic review of observational studies reported endometrial 
hyperplasia (EH) without atypia rates between 0.2–23.8% in polyps [23]. The prevalence of 
premalignant atypical endometrial hyperplasia (AEH) appears to be lower with estimates in primary 
studies ranging from between 1% and 3% [24, 25, 26, 27].  
Endometrial polyp cancer prevalence has been reported to range from 0.5–3% [28, 29, 30, 31, 32, 
24, 25, 26].   
Risk factors for malignancy within uterine polyps include abnormal uterine bleeding, increasing age, 
postmenopausal status, obesity, diabetes [24, 25, 26] an increased polyp size [26, 27] and tamoxifen 
[14, 33].  Another systematic review reported the prevalence of endometrial hyperplasia or cancer 
within polyps in women with symptomatic bleeding as 4.2% (195/4697) compared with 2.2% 
(85/3941) for those without bleeding (relative risk (RR) 1.97; 95% confidence interval (CI) 1.24 to 
3.14). The risk of pre-malignancy or malignancy within a uterine polyp was higher in symptomatic 
postmenopausal women (5.4%, 214/3946) compared with 1.7% (68/3997) in reproductive-aged 
women (RR 3.86, 95% CI 2.92 to 5.11). 
 
[B] Abnormal uterine bleeding 
 
The high prevalence of uterine polyps in women with all forms of AUB, namely HMB, IMB and PMB, 
has become increasingly apparent with the widespread adoption of high-resolution pelvic 
ultrasound and greater access to outpatient hysteroscopy. In addition to this observation of high 
prevalence in women with AUB, causality has also been inferred from the effect of removing polyps 
on bleeding symptoms. Collated evidence from systematic reviews have found that alleviation or 
improvement in AUB symptoms is generally observed following polypectomy (range 75–100%) [34] 
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at follow-up intervals of between 2 and 52 months. However, these studies were generally 
uncontrolled small series. Moreover, reliable stratification of treatment outcome according to type 
of abnormal bleeding was not possible in these reviews. Recent RCTs have provided additional data 
on treatment outcomes in AUB following polypectomy and this is discussed in more detail in the 
treatment section of this chapter.  
 
The mechanism by which polyps arising from the endometrium precipitate these different forms of 
AUB remains uncertain and may be linked to the equally unclear underlying aetiology of polyp 
formation. Thus, factors such as altered responses to oestrogen and progesterone compared to the 
background endometrium, inflammatory changes and disturbed angiogenesis may be involved but 
these possible explanations remain speculative. Attempts are being made to produce a practical and 
reproducible sub-categorisation system of the AUB-P category within the PALM COEIN nomenclature 
[20]. By developing such a system based upon features such as the number, size, shape, location, 
composition and vascularity of polyps it is hoped that questions pertaining to the significance of 
uterine polyps found in association with particular AUB presentations may be more readily 
answered. 
 
[A] Diagnosis of endometrial polyps in abnormal uterine bleeding 
In women with abnormal uterine bleeding in whom endometrial polyps are suspected there are 
three main modes of investigation.  
[B] Ultrasound 
Initial assessment of endometrial disease is often via radiological imaging. Ultrasound (USS) is 
usually the first imaging modality and has the advantage of providing information on the size of the 
uterine cavity and other pathology including leiomyomas. It is non-invasive and therefore generally 
acceptable to the majority of patients with minimal discomfort. With plain transvaginal ultrasound 
(TVS) a polyp appears as endometrial thickening or with the more typical appearance of a 
hyperechoic lesion within the uterine lumen with a regular contour and surrounded by a thin 
hyperechoic halo [35]. Transvaginal ultrasound is more accurate when performed in the proliferative 
phase of the menstrual cycle [36]. The accuracy of TVS in diagnosing uterine polyps varies across test 
accuracy studies with accuracy estimates ranging from sensitivities of 19-96%, specificities between 
53-100% and positive predictive values of between 75 and 100% and negative predictive values of 
87-97% when compared to hysteroscopy and guided biopsy [37]. In general, TVS appears to have a 
good degree of accuracy when performed with high resolution equipment by proficient 
practitioners. Polyp size should be assessed at the time of US as this can provide vital information, 
useful in aiding management. An increase in the diameter of the polyp appears to correlate with risk 
of malignancy [30] with smaller polyps being more likely to resolve spontaneously [22]. 
Further enhancement with Colour flow Doppler or Power Doppler can be used to improve diagnostic 
accuracy when using TVS to assess the endometrial cavity. Colour flow Doppler is useful in 
demonstrating the single feeding vessel seen with endometrial polyps and Power Doppler of the 
vascularity has been shown to improve diagnostic accuracy when looking at endometrial polyps in 
both asymptomatic and symptomatic women [38]. There is, however limited evidence that either 
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power Doppler or colour flow Doppler increases the diagnosis of malignancy or hyperplasia within 
polyps and therefore histological diagnosis is still necessary following detection via TVS.  Power 
Doppler has been reported to be more accurate than colour flow for demonstrating vascular 
networks in one study looking at postmenopausal women with abnormal bleeding and thickened 
endometrium on baseline US [38].  
The addition of intra-uterine contrast via saline infusion sonography (SIS) or gel installation 
sonography (GIS) may be used to improve diagnostic accuracy compared to TVS alone. With SIS the 
fluid allows better contrast between the endometrial cavity allowing for delineation of the base or 
stalk of the polyp and improving detection of smaller polyps which may have been missed by TVS 
alone [39].  In contrast to SIS, there is currently limited data on the accuracy of GIS in diagnosing 
uterine polyps.  
When comparing SIS with hysteroscopy, SIS had a sensitivity of 58-100%, specificity 35-100%, PPV 
70-100% and NPV83-100% [36]. A systematic accuracy review using hysteroscopy with or without 
biopsy or hysterectomy as reference standards found that the accuracy of SIS in the diagnosis of 
endometrial polyps was lower compared with diagnosing other uterine cavity abnormalities such as 
submucous fibroids. The pooled sensitivity was 0.86 (95% CI 0.81 to 0.91) and the pooled specificity 
was 0.81 (95% CI 0.72 to 0.88) and the likelihood ratios (LRs) were respectively 5.23 (95% CI 3.98 to 
6.90) and 0.12 (95% CI 0.08 to 0.17) consistent with a moderately accurate test for detecting and 
excluding polyps [40] Saline infusion sonography simultaneously allows for assessment of other 
pelvic structures including the adnexa and myometrium as well as the uterine cavity and tubal 
patency and therefore provides a useful adjunct to TVS especially when assessing patient’s pre-
operatively to decide on the procedure most likely to benefit the patient. The main disadvantage of 
SIS and GIS is the increased level of operator training needed compared to TVUS alone as well 
patient discomfort during the longer examination 
3D USS has been used in assessment of the endometrium but showed limited improvement in 
diagnosis compared to 2D TVS [41] although this is slightly improved with the addition of 
intrauterine contrast. One study reported high accuracy of 3D USS in diagnosing uterine polyps with 
a derived sensitivity of 100%, specificity 99%, PPV 99% and NPV 100% compared to hysteroscopy 
and guided biopsy [36].  
[B] Hysteroscopy 
The gold standard investigation for diagnosis of endometrial polyps is hysteroscopy and guided 
biopsy. Hysteroscopy has the advantage of allowing the practitioner to directly visualise the 
endometrium and remove any polyps at the same time for histological diagnosis meaning the 
patient does not have to return for treatment. It also gives the advantage of detecting other 
endometrial pathology such as submucous fibroids which may also be treated at the same time or 
assessed for further treatment at a later operation. The overall complication rate for hysteroscopy is 
small but increased compared to USS imaging alone with the overall risk of serious complications 2 
in 1000 women [42]. A systematic review comparing hysteroscopy with hysteroscopically directed 
biopsy or hysterectomy [43] showed a high degree of accuracy with a pooled sensitivity of 0.94 (95% 
CI 0.92–0.96) and specificity of 0.92 (95% CI 0.91–0.94). The corresponding positive and negative 
likelihood ratios were 12.9 (95% CI 8.0–20.9) and 0.09 (95% CI 0.06–0.14) respectively. The ability to 
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exclude a polyp was higher in women after the menopause which may reflect easier visual 
discrimination of a focal endometrial lesion from the thin inactive background endometrium 
(premenopausal women LR+ 33.5, 95% CI 8.2–136.0 and LR- 0.16, 95% CI 0.09–0.28; 
postmenopausal women LR+ 12.0 (95% CI 4.0–35.8) and LR- 0.04 (95% CI 0.01–0.26)  
 
Whilst hysteroscopy has high accuracy for the diagnosis of endometrial polyps, the test involves a 
subjective assessment of the size and features of the polyp and directed biopsy should therefore be 
performed, even if the polyp appears benign and is not causing symptoms. Diagnostic hysteroscopy 
missed endometrial hyperplasia in 0.9% of patients in one large RCT and had a lower sensitivity and 
positive predictive value than hysteroscopy with directed biopsy [44]. A large systematic review and 
meta-analysis of hysteroscopy has however demonstrated the high accuracy of the test in malignant 
and pre-malignant endometrial disease although this did not specifically relate to cancer or 
hyperplasia within a uterine polyp [45]. 
Hysteroscopy is frequently performed in the outpatient setting with greater patient satisfaction with 
the outpatient procedure and similarly high success rates of 92-6% [46]. Care should be sought over 
the equipment used in outpatient hysteroscopy. Flexible hysteroscopy may be used owing to the 
reduction in patient discomfort over the use of rigid scopes however 2 prospective studies have 
revealed reduced accuracy when assessing for endometrial polyps with flexible hysteroscopy giving a 
sensitivity of 74% and specificity of 90% [47].    
[B] Endometrial biopsy 
Pelvic examination of women with abnormal uterine bleeding may provide an opportunity for blind 
sampling of the endometrium using miniature aspiration devices most being based upon the Pipelle® 
biopsy prototype or traditional dilatation and curettage (D&C). These blind techniques fail to sample 
a significant proportion of the endometrial cavity and so not surprisingly for focal pathologies like 
uterine polyps, blind biopsy has low accuracy compared with hysteroscopy and guided biopsy [48, 
49]. This technique will frequently miss polyps particularly if small or pedunculated and makes 
histological diagnosis more difficult due to the tissue fragmentation. Histology is also unable to 
confirm the polyp has been removed at the base and therefore blind biopsy should not be used as a 
diagnostic test when investigating for endometrial polyps.   
 
[A] Treatment of endometrial polyps in abnormal uterine bleeding 
[B] Expectant management 
The surgical treatment of uterine polyps is excision or ‘polypectomy’. Uterine polypectomy is one of 
the commonest procedures in contemporary gynaecological practice. Surgical removal aims to treat 
associated symptoms such as AUB or subfertility and also to obtain tissue for histological 
examination. A UK national survey [50] and two subsequent Dutch surveys [69, 70] confirmed that the 
vast majority of gynaecologists advocated surgical removal of polyps from the uterus after diagnosis. 
However, the need to universally remove uterine polyps may be questioned in light of the 
observations that polyps are found incidentally in around 5–15% of women [11, 9, 10, 12] ,most are 
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benign [53, 54] and some may regress spontaneously [22, 21]. Two randomised controlled trials 
(RCTs) have addressed this issue, randomising women with AUB and uterine polyps to expectant 
management or surgical removal [53, 54]. One of these RCTs randomised 150 pre-menopausal  
women with uterine polyps, of which 60% had AUB symptoms. Overall, no reduction in periodic 
blood loss was demonstrated at 6 months following surgical excision but IMB symptoms were 
significantly improved [54].  
Another RCT [56] attempted to determine the significance of uterine polyps on the risk of recurrent 
post-menopausal bleeding (PMB) by randomising women with PMB to either polypectomy versus 
expectant management. However, the lack of equipoise of both patients and their clinician’s 
hindered recruitment so that the trial could not be completed. The authors then redesigned their 
RCT to overcome the observed reluctance to leave a hysteroscopically detected uterine polyp in situ 
[57]. Women with PMB and a thickened endometrium on TVS and a subsequently benign 
endometrial biopsy were randomised to undergo further testing with a hysteroscopy or no further 
investigation. Women allocated hysteroscopy who were found to have a uterine polyp had it duly 
removed. The same polyp prevalence was assumed in the expectant group and so the impact of 
polypectomy on recurrent PMB at 12 months could be assessed. Nearly one in five women 
experienced recurrent PMB over the year but no differences in prevalence of recurrent PMB were 
seen between groups. Thus expectant management on symptomatic grounds seems a viable option 
as opposed to hysteroscopic polypectomy. The RCT was however underpowered. Of great interest 
was the finding that there was a 6% incidence of atypical hyperplasia or cancer in the 
hysteroscopically removed polyps. Thus, hysteroscopic polypectomy appears to be indicated to aid 
diagnosis of serious endometrial disease but not to alleviate bleeding symptoms.  
[B] Medical management 
Evidence supporting the use of medical treatment of uterine polyps is lacking although hormonal 
treatments are widely used to treat menstrual complaints of which some will be associated with 
uterine polyps. Pre-treatment with gonadotrophin-releasing hormone analogues (‘GnRH-a’s) prior to 
hysteroscopic resection of focal pathologies in premenopausal women [57]has been reported but 
the costs and morbidity of this intervention is unjustifiable given the relative simplicity and success 
of removing uterine polyps as opposed to more technically challenging submucosal fibroids. Rather 
than using medical therapies to directly treat polyps, medical treatments have been examined to 
prevent their formation. For example the use of the levonorgestrel-releasing intrauterine system 
(LNG-IUS) in women taking tamoxifen may reduce the incidence of endometrial polyps [60, 61].   
 
[B] Surgical management 
The surgical removal of intrauterine polyps can be achieved blindly or under direct hysteroscopic 
vision. 
[C] Blind polypectomy 
Blind removal of uterine polyps utilising ‘dilatation and curettage’ (D&C) under general anaesthetic 
or avulsion with polyp forceps has yet to be fully consigned to its rightful place in the history books. 
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National surveys from the UK and Netherlands [50, 51, 52] albeit from a decade or so ago, still 
indicate that such practices are common place. The technique involves wide dilatation of the cervix 
and the use of standard surgical polypectomy forceps to explore the uterine cavity. These 
approaches can be associated with potential uterine trauma and visceral trauma [60].Incomplete 
removal of polyps is also are well recognised [62, 63, 64]. Most gynaecologists would perform a 
hysteroscopy beforehand to locate the polyp to direct blind avulsion of the lesion followed by 
curettage [50].  
[C] Hysteroscopic uterine polypectomy 
Advances in hysteroscopic technology have enabled polyps to be removed under direct vision using 
fine mechanical and electrosurgical equipment which are passed down a 5- or 7-French working 
channel of a rigid, continuous flow operating hysteroscope [8, 63, 66, 34]and more recently the 
introduction of bespoke tissue removal systems [67, 68]. All these techniques require hysteroscopic 
visualisation within the uterine cavity, excision of the polyp tissue from the uterine wall and retrieval 
from the uterine cavity. Traditional approaches to inserting the hysteroscope have entailed the use 
of a vaginal speculum, cervical instrumentation and local anaesthesia. However, vaginoscopic 
approaches are increasingly being adopted avoiding the use of vaginal instrumentation thereby 
minimising pain and allowing the operator greater degrees of movement externally to facilitate 
manipulations within the uterine cavity during the surgical procedure [69]. 
 
 [D] Mechanical 
Uterine polyps can be removed by excision or avulsion using a variety of fine mechanical instruments 
in isolation or combination. Such ancillary instruments include reusable scissors, biopsy cups, forceps 
and disposable polyp snares (Figure 2). The safety, feasibility and efficiency of such approaches have 
been well reported [8, 64, 65, 34] However, fragility of the instruments preclude the excision or 
avulsion of large or fibrous polyps and bleeding may occur [69]. The limited degree of movement of 
these instruments can also limit feasibility. The diameter of the cervical canal relative to the excised 
polyp creates challenges to removing pathology as polyp tissue may slip from the small diameter 
grasping forceps when attempting retrieval down the endo-cervical canal. In such circumstances the 
operator will have to consider blind dilatation of the cervix to allow further attempts at 
hysteroscopic retrieval with grasping forceps or the use of polyp snares. Recourse to blind retrieval 
of a detached polyp using standard polyps forceps should not be attempted routinely. In the authors 
opinion, blind retrieval in this way should only be attempted where histological examination of a 
suspicious looking polyps is considered necessary because the risks of uterine and intra-abdominal 
trauma are not insignificant especially if the procedure is to be carried out under general 
anaesthesia [1]. In general, hysteroscopic polypectomy using small diameter mechanical instruments 
should be limited to smaller, glandular polyps. 
[D] Electrosurgical 
The application of electricity has enhanced the cutting potential of hysteroscopic instruments such 
that the limitations of fine mechanical technologies are overcome, namely the removal or larger and 
more fibrous polyps. Large-diameter hysteroscopic resectoscopes can be used under general 
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anaesthesia or conscious sedation. The resecting loop can be used to remove the polyp in strips with 
repeated passes of the cutting loop or en bloc by cutting the base of the polyp where it adjoins the 
uterine side wall. However, whilst the use of formal resectoscopes is quick and effective, a greater 
degree of specialised hysteroscopic skills are required [70, 71] cervical and uterine trauma can result 
from the need for blind cervical dilatation along with complications arising from fluid overload and 
inadvertent electrosurgical injury [72]. Moreover, given the fully intra-cavity position and generally 
soft nature of most polyps, the resectoscope is a somewhat ‘overpowered’ technology and in the 
authors opinion these technologies are better employed for the removal of firmer and more deeply 
sited submucous fibroids . The use of a 5.3mm (16 Fr gauge) mini-resectoscope has been described 
for use in the inpatient and outpatient setting but this technology has not been widely adopted [73].   
Advances in hysteroscopic electrosurgical technologies include improvement in visualisation and 
image quality, the development of safer bipolar systems and miniaturisation of equipment such that 
uterine trauma can be minimised and procedures performed without the need for general 
anaesthesia or sedation. A miniature bipolar electrosurgical system (Figure 3) has been developed 
(Versapoint,Gynecare, Ethicon, Somerville, NJ, USA) to cut away polyps and the safety, acceptability 
and feasibility of this approach has been reported {74, 75, 76 ]. The Versapoint® bipolar electrodes 
are single use but reusable electrodes are available e.g. the bipolar dissection electrode (Karl Storz, 
Tuttlingen, Germany).  However, as with small diameter mechanical instruments, retrieval of larger 
or fibrous tissue specimens from the uterine cavity, especially where the diameter of the endo-
cervical canal is restricted, remains problematic. Mechanical instruments such as hysteroscopic 
graspers, biopsy cups and snares are required to retrieve the specimen with the limitations as 
outlined in the preceding section. In general, the authors favour the efficient en-bloc electrosurgical 
removal of a polyp by detaching it directly from its base but where larger or fibrous polyps are 
identified, then removal piecemeal by cutting several strips of tissue may be preferable because 
difficulty with retrieval from the uterine cavity can be anticipated. However, such an approach is 
more cumbersome and usually results in a longer intrauterine operating time which can be 
disadvantageous especially in an outpatient setting [8].  
Disposable hysteroscopic polyp snares are available (Cook Medical, Bloomington, USA). The snare is 
passed down the operating channel of the hysteroscope and opened to ensnare the polyp which is 
detached by the application of monopolar energy and then removed by withdrawing the entire 
hysteroscopic system from the uterine cavity [65]. The ease at which polyps can be ensnared 
depends upon their location and size. A non-conducting medium such as glycine or sorbitol is 
required. Snares can also be used without activating current in order to retrieve previously detached 
polyps (see above).  
The main limitations of using miniature electrosurgical cutting instruments include potential thermal 
complications arising from uterine perforation and the inability to retrieve detached tissue 
specimens from the uterine cavity down the relatively narrow endo-cervical canal. Recognition of 
these problems and a desire to overcome them has led to the development of hysteroscopic tissue 
removal systems.   (TRUCLEAR™, Smith & Nephew, Andover, MA, USA),  Myosure (Hologic, 
Marlborough, MA, USA) and the IBS® - Integrated Bigatti Shaver (Karl Storz, Tuttlingen, USA), which 
allow simultaneous tissue cutting and extraction.813299,100 More recently the SYMPHION
TM
  
(Boston Scientific, Natick, MA) has been produced which combines a tissue removal system with 
bipolar radiofrequency energy. 
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[D] Tissue removal systems 
Hysteroscopic tissue removal systems have been developed to remove focal pathologies such as 
polyps and submucous fibroids without the need for electrical energy [77]. Tissue removal systems 
allow simultaneous mechanical cutting and tissue aspiration allowing clear views as debris from 
uterine polyps, fragmented endometrium or in the case of SMFs ‘fibroid chips’ are prevented. The 
TRUCLEAR™ and MyoSure™ tissue removal systems consist of a bespoke 0° hysteroscope (IBS® 6° 
distal lens) with an operating channel through which a disposable cutting hand piece attached to 
external suction tubing is passed (Figure 4). This hand piece comprises of two rotating hollow metal 
tubes each with a small distal window with serrated edges or a rotary blade edges through which the 
tissue is cut and retrieved. The removed tissue is sucked through the device and trapped in a tissue 
collector within the external suction housing.  The control unit consist of a generator providing the 
electrical energy to rotate the mechanical tissue removal system and a digital display.  
Currently available tissue removal systems come in a variety of specifications as regards their size 
and cutting mechanism. In general the smaller devices are suitable for polyps whereas the larger 
systems are designed for removing firmer fibroid tissue. The TRUCLEAR™system was the first to be 
developed and marketed; the TRUCLEAR™ 5C system provides continuous flow if the outer irrigating 
sheath is used. The outer diameter is 5.7mm, a diameter that avoids the need for routine cervical 
dilatation making it suitable for outpatient based procedures and this can be reduced to 5mm if the 
outer sheath is dispensed with (the suction down the hollow tubes providing irrigation). The 
TRUCLEAR™ 8.0 set is 9mm in outer diameter containing a larger optic and working channel to house 
the rotary blade. The MyoSure™ system utilises hysteroscopes of 6 mm and 7 mm according to the 
particular cutting system used. The IBS® system uses an 8mm operating hysteroscope 
The techniques are simple, essentially approximating the cutting aperture of the hand piece to the 
polyp and ensuring cutting and aspiration of tissue continues without interruption via small, gentle 
manipulations of the hysteroscope and hand piece.  To prevent blood and debris obscuring the 
visual field it is important to keep the device activated to ensure these products will be sucked into 
the window.  The technique is much simpler than traditional electrosurgical resection of fibroids or 
polyps such that any learning curve for trainees is negligible [66].   
 
[B] Evidence for polypectomy in treating abnormal uterine bleeding 
Two systematic reviews support the notion that removing uterine polyps is effective at improving 
symptoms of AUB. However, the quality of the research was generally poor consisting mainly of 
uncontrolled observational series with heterogeneous populations, length of follow up and outcome 
assessment, such that it remained unclear whether menopausal status or the type of AUB e.g. IMB 
or HMB influenced the treatment outcome. Large RCTs were recommended to compare 
conventional polypectomy with conservative management as well as traditional inpatient with novel 
outpatient approaches to polyp treatment to identify best practice before opinion is solidified [34, 
23, 36]. Since these reviews were published, three RCTs have been performed and published [54, 78, 
56].  
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Two of these RCTs support the role of polypectomy for treating AUB found in association with AUB 
[54, 78]. The outpatient polyp treatment (OPT) trial [78] was an RCT comparing the effectiveness of 
inpatient polypectomy under general anaesthesia for the treatment of AUB (HMB, IMB, PMB, AUB 
on HRT / Tamoxifen) with outpatient treatment in conscious women with or without the use of local 
anaesthesia. Blind and hysteroscopic approaches to surgery were allowed and the latter included 
mechanical or electrosurgical energy. The majority of women were alleviated of their AUB symptoms 
at six months (73% (166/228) of women who received outpatient treatment and 80% (168/211) who 
received inpatient treatment) and the treatment effects were maintained at 12 and 24 months. 
There was no evidence that successful resolution of symptoms varied by primary bleeding complaint 
(i.e. HMB, IMB, PMB), or polyp type and location. Significant improvements in generic and disease 
specific quality of life were also observed after polypectomy. However, this RCT had no placebo 
group because it was designed to look at differences in AUB outcomes for polypectomy according to 
treatment setting rather than the more fundamental question pertaining to the effectiveness of 
uterine polypectomy. 
However, two RCTs did compare uterine polypectomy with expectant management [54, 56]. One 
RCT evaluated transcervical resection of endometrial polyps against a policy of observation alone in 
150 premenopausal women of which only 60% had AUB symptoms. Overall, no reduction in periodic 
blood loss as assessed using pictorial blood assessment charts (PBACs) was demonstrated at 6 
months’ follow-up, but IMB and vaginal discharge symptoms were significantly improved (ongoing 
IMB symptoms in 7/75 treated patients (9.3%) vs. 28/75 control patients (37.3%); p < 0.001). [54] 
The other RCT was restricted to postmenopausal women with bleeding. The original design was 
similar to the aforementioned RCT in pre-menopausal women i.e. a simple polypectomy versus 
expectant management but recruitment was not possible because of lack of equipoise in both 
patients and their clinicians [55]. The redesigned RCT simply randomised women with benign disease 
after diagnostic work up with TVS and EB between hysteroscopy (with polypectomy if a polyp was 
detected) and expectant management as described earlier [56]. The same polyp prevalence was 
assumed in the expectant group and so the impact of polypectomy on recurrent PMB at 12 months 
could be assessed.  
Hysteroscopic polypectomy did not reduce the likelihood of recurrent PMB so treatment on 
symptomatic grounds appears to lack justification, although the lack of power in the RCT cannot 
exclude polypectomy as an effective treatment for AUB. However, a 6% incidence of serious 
endometrial disease (atypical hyperplasia or cancer) was detected in the removed polyps. Thus 
hysteroscopic polypectomy is indicated to aid diagnosis of serious endometrial disease but not to 
alleviate bleeding symptoms. These findings raise interesting questions about the aetiology of PMB 
and the validity of recommendations on the diagnostic work up of PMB [80] as these are based upon 
a probable overinflated estimate of the accuracy of outpatient endometrial biopsy (blind dilatation 
and curettage being the usual reference standard rather than hysteroscopically directed biopsy).  
Thus, it remains unclear as to the best policy for managing uterine polyps diagnosed during 
investigations for AUB. The majority of women appear to have their symptoms alleviated after 
polypectomy but it is uncertain whether the removal of the lesion accounts for this desirable 
outcome. However, the hysteroscopic removal of polyps appears to be safe, with a low complication 
rate noted in all three RCTs [54, 78, 56] (the OPT trial recorded four uterine perforations (4/233, 2%) 
with one associated bowel injury following blind, as opposed to hysteroscopically directed  removal 
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techniques in inpatient women under general anaesthesia; no such complications were noted in the 
outpatient group [78] and in symptomatic postmenopausal women removal seems important to 
exclude pre-malignant and malignant disease. 
 
[B] Treatment setting 
Uterine polypectomy could only be conducted in the past using blind interventions, namely D&C and 
avulsion with forceps. To introduce such instruments required dilatation of the cervix and 
manipulation within the uterine cavity, manoeuvres that necessitated the use of general 
anaesthesia. Technological advances have facilitated polyp removal under direct hysteroscopic 
vision using small diameter endoscopes. The increased precision of surgery and avoidance of the 
need for routine substantial dilatation of the cervix has meant this common gynaecological 
procedure can be conducted in the outpatient setting and without general anaesthesia. Indeed often 
no local anaesthesia is required especially when using hysteroscopic systems under 6mm in outer 
diameter and adopting a vaginoscopic approach [68]. Direct cervical injection or paracervical 
injection of local anaesthesia is used where cervical dilatation is required. Intrauterine instillation or 
injection of local anaesthesia has been the subject of recent studies but there is no evidence to 
support its use nor the use of conscious sedation for uterine polypectomy [80, 81]. Many studies 
have reported the feasibility including acceptability of small diameter mechanical and electrosurgical 
techniques for outpatient polypectomy. However, these techniques have not been widely adopted 
despite such studies. This may relate to a lack of skills, access to contemporary endoscopic 
technologies, embedded clinical prejudices or a concern that outpatient procedures being limited by 
patient factors may result in poorer clinical outcomes such as resolution of AUB. A recent large, 
multicentre RCT based in the UK involving more than 30 outpatient hysteroscopy units has been able 
to answer the latter question regarding the relative effectiveness of outpatient versus inpatient 
uterine polypectomy [78].  
 
[C] Evidence for outpatient treatment 
The results of the Outpatient Polyp Treatment trial (OPT trial) showed that outpatient polypectomy 
was not inferior to inpatient polypectomy for the successful alleviation of uterine bleeding 
associated with uterine polyps. At six months 73% (166/228) of women who received outpatient 
treatment and 80% (168/211) who received inpatient treatment were successfully treated, and the 
treatment effects were maintained at 12 and 24 months. There was no evidence that successful 
resolution of symptoms varied by primary bleeding complaint (i.e. HMB, IMB, PMB), polyp type 
(fibrous or glandular) and location (fundal vs. non-fundal). An equivalent and significant 
improvement in generic and condition specific quality of life was seen after polypectomy. 
Importantly there were fewer serious complications in the outpatient group; no uterine perforation 
compared with four in the inpatient group (including one bowel injury). However the study was too 
small to categorically answer the question as to the safest treatment setting and operative 
techniques employed [78].  
A patient preference study (cohort study) was run along alongside the RCT side for women with a 
strong treatment setting preference precluding randomisation [1] 81% of the 399 women in this 
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study expressed a preference for outpatient treatment and a formal qualitative study utilising semi-
structures interviews and thematic analysis confirmed that the immediacy of treatment, avoidance 
of hospital admission, time off work and overall convenience of an outpatient procedure was highly 
valued [1]. However, outpatient polypectomy was associated with more technical failures (18% 
versus 7%), increased postoperative pain, and reduced acceptability to patients. The differences in 
post-operative pain scores and acceptability were marginal and unlikely to be of clinical significance.  
Average pain scores during the outpatient procedure were of moderate intensity but low 
postoperatively, and our qualitative research suggested that women believed that the discomfort of 
outpatient treatment was outweighed by convenience. Moreover, the differences may reflect the 
shorter interval between intervention and pain assessment before leaving the outpatient clinic. The 
clinical importance of differences in acceptability should be interpreted in light of the high overall 
levels of patient acceptability and the convenience of outpatient treatment (98% of women found 
the procedure acceptable in both outpatient and inpatient groups).  
However, what about technical success? Technical success was defined as complete excision 
(detachment) and retrieval of the polyp tissue from the uterine cavity. The fact that failure to 
completely remove polyps was higher in conscious women may reflect the limitations of miniature 
endoscopic equipment and patient tolerability. However, tissue removal systems (TRS) were 
unavailable at the time of recruitment to the study (2008-2011). Whilst the OPT trial utilised variety 
of polypectomy techniques (blind, hysteroscopic (mechanical or electrosurgical), the absence of TRS 
is likely to be clinically important [78]. This is because the MERT trial comparing electrosurgery using 
Versapoint compared with TRS using the TRUCLEAR system, showed a comparable failure rate 
(49/59; 17%) for miniature Versapoint bipolar electrosurgery compared with that seen in the 
outpatient arm of the OPT trial (67). However, the failure rate in the TRUCLEAR group was 
substantially lower (1/62, 2%). Thus, ongoing technological advances and refinement of treatment 
protocols are improving feasibility. Moreover, outpatient hysteroscopy clinics have become common 
place but the ability to effect treatments rather than simple diagnostic procedures is less well 
advanced. Practitioners may require additional training to become competent in therapeutic 
outpatient procedures. However, proficiency should be quickly acquired given the familiarity of 
diagnostic outpatient hysteroscopy and the relative simplicity of uterine polypectomy. 
The available evidence for effectiveness, feasibility and acceptability of outpatient polypectomy for 
AUB at worst supports equivalence with conventional inpatient polypectomy under general 
anaesthesia. Thus, the only obstacle to widespread adoption of the outpatient setting is economics 
namely the relative cost-effectiveness of outpatient versus inpatient treatment.  The inflated cost of 
miniaturised technologically advanced equipment required for most outpatient procedures may 
offset the efficiency of outpatient polypectomy even when it is performed immediately following 
diagnosis at OPH – the ‘see and treat’ approach. To answer this question a formal economic 
evaluation was carried out alongside the multi-centre, pragmatic, non-inferiority, randomised 
controlled Outpatient Polyp Treatment (OPT) trial (82]. The results showed that inpatient treatment 
was slightly more effective but substantially more expensive than outpatient treatment. Incremental 
cost-effectiveness ratios at 6 months revealed that it cost an additional £9421 per successfully 
treated patient in the inpatient group and £1,099,167 per additional quality of life year (QALY) 
gained, when compared with outpatient treatment. At 12 months, these costs were £22,293 per 
additional effectively treated patient and £445,867 per additional QALY gained, respectively. Thus, 
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outpatient treatment of uterine polyps associated with AUB appears to be more cost-effective than 
inpatient treatment at willingness-to-pay thresholds acceptable to the NHS. 
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Summary (250 words) 
Endometrial polyps are commonly found in association with abnormal uterine bleeding. They affect 
women of reproductive and post-reproductive age. Their underlying aetiology is debated but most 
are benign. Hysteroscopy is the gold standard diagnostic test although 2D ultrasound scan, especially 
with saline or gel contrast, has good accuracy also. Hysteroscopic diagnosis is increasingly performed 
in an outpatient setting in conscious patients. Furthermore, technological advances have facilitated 
surgical removal of endometrial polyps in the outpatient setting, which can often be conducted 
immediately following hysteroscopic diagnosis in the same sitting. This immediacy of treatment and 
convenience is highly valued by women. Blind polyp removal using large diameter curettes and polyp 
forceps is outdated and risks incomplete excision, non-retrieval of specimens and uterine trauma. 
Hysteroscopic removal using mechanical and electrosurgical instruments is successful and has been 
made increasingly feasible with the recent introduction of bespoke tissue removal systems. The 
majority of women with heavy menstrual bleeding, intermenstrual bleeding or postmenopausal 
bleeding report an improvement in symptoms following polypectomy although few placebo 
controlled trials have been conducted. Further research is needed to better understand the 
aetiology, natural history, oncogenic potential and significance of these common intrauterine 
pathologies as well as the benefits of surgical removal including resolution of abnormal bleeding 
symptoms and detection of serious endometrial disease. The development of a polyp sub-
classification may help standardise research so we can more readily address these questions. 
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Practice points 
• Endometrial polyps should be considered as a potential cause for abnormal uterine bleeding 
• Hysteroscopy is the most accurate outpatient test for diagnosing endometrial polyps. 
Transvaginal ultrasound especially with saline or gel contrast is an acceptable second best 
alternative. 
• Diagnosis at outpatient hysteroscopy allows for simultaneous surgical removal which is more 
convenient for most women 
• Blind polyp removal using large diameter curettes and polyp forceps is outdated and risks 
incomplete excision, non-retrieval of specimens and uterine trauma. 
• Hysteroscopic removal using mechanical and electrosurgical instruments is safe, feasible and 
acceptable whether conducted under general anaesthesia or in an outpatient setting with 
local or no anaesthesia. 
• Tissue removal systems appear to be associated with quicker, more successful and less 
painful outpatient polypectomy and more readily obtain tissue for histological examination 
as cutting and aspiration of removed polyp tissue occurs simultaneously. 
• Polypectomy should be conducted in women with postmenopausal bleeding because 6% 
harbour atypical endometrial hyperplasia or cancer 
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Research Agenda 
• Develop a polyp sub-classification system to standardise research so that the aetiology, 
natural history, oncogenic potential and clinical significance of endometrial polyps can be 
better understood  
• Conduct further placebo controlled trials to elucidate the effectiveness of endometrial 
polypectomy on symptoms of abnormal uterine bleeding and better understand their clinical 
significance and natural history 
• Design studies comparing hormonal regulation/suppression of the endometrium on polyp 
regression, recurrence and associated bleeding symptoms with surgical removal 
• Develop operating protocols to optimise the patient experience during outpatient surgical 
removal of polyps 
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Table 1 
Definition of an endometrial polyp according to diagnostic test 
Diagnostic test Definition 
  
Hysteroscopy A discrete outgrowth of endometrium, attached by a pedicle, which 
moves with the flow of the distension medium. Polyps may be 
pedunculated or sessile, single or multiple and vary in size (the 
variable amount of glands, stroma and blood vessels that constitute 
the polyp will influence their macroscopic appearance[8.] 
 
Ultrasound Non- specific endometrial thickening or a focal mass identified as 
an echogenic lesion which disturbs the midline endometrial echo 
but does not disrupt the interface between the myometrium and 
endometrium. The lesion is usually oval shaped with a homogenous 
texture although hypoechoic cystic spaces may be seen. Blood flow 
may be identified within a feeding vessel extending to the polyp on 
colour Doppler imaging. Saline infusion sonography and 3D 
ultrasound help delineate the borders of the intra-cavity lesion. [35,  
85,86] 
 
Hysterosalpingogram Filling defects within the uterine cavity 
 
Magnetic resonance imaging Isointense (Tesla 1) or hypointense (Tesla2) masses within the 
uterine cavity. Tesla 1 contrast enhancement with gadolinium can 
show either homogeneous or heterogeneous enhancement. [87] 
 
Histological sampling
1 
Endometrial tissue showing at least two of: (i) glandular 
architectural disarray, (ii) stromal fibrosis and (iii) enlarged, thick-
walled stromal blood vessels. Benign ‘simple’ polyps may be 
covered with functional endometrium (reproductive age) or 
atrophic (post-reproductive age). They may be described as 
glandular-cystic, fibrous, glandular-fibrous according to the relative 
preponderance of glandular and stromal components. 
Adenomyomatous polyps contain prominent bundles of smooth 
muscle within the stroma and adenomatous polyps have many 
glands with an intensively proliferating epithelium. Hyperplastic 
polyps have a hyperplastic epithelium with or without cytological 
atypia. Polyps may more rarely contain intraepithelial carcinomas 
or be frankly malignant.  
 
1 Biopsy may be blind or directed; the oval, polyp shape will be seen if surgically removed en bloc  
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Figure 1 
Hysteroscopic appearance of an endometrial polyp 
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 Figure 2 
Small diameter, 30° rigid continuous flow operating hysteroscope. 5 Fr mechanical instruments 
shown for use down the working channel 
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Figure 3 
Small diameter, 0° Alphascope®. Note the disposable outer sheath containing the inflow and 
working channels. The sheath can be rotated to manipulate the hysteroscopic instruments within 
the uterine cavity. Mechanical (5 & 7 Fr) and electrosurgical bipolar electrodes (5 Fr) can be used. 
The Versapoint® twizzle tip and spring tip electrodes are shown. These 5 Fr electrodes can be used 
with other types of rigid operating hysteroscope 
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Figure 4 
Truclear® Tissue Removal System. The system consists of a 0°bespoke hysteroscope generator to 
power the rotating blades within the disposable handpiece which in rune is attached to external 
suction tubing. Tissue is simulatneouls cut and aspirated providing clear views and immediate tissue 
removal. Note the off-set proximal eye piece to allow the instrument to be passed down the working 
channel.  
